Dashboard
Investment deals 
Investor briefings
Company alerts
Investment news
Investment videos
Stock trackerInvestment news
Using novel test, US healthcare providers can test patients’ NAD+ levels at home or in the clinic. Doctors in the US can now access a novel NAD+ blood diagnostic for…
The latest longevity updates from our investment news desk. Celmatix unveils largest endometriosis study Ovarian longevity company Celmatix announced findings from its long-term collaboration to decode the genetic basis of…
Joe Betts-LaCroix on investing in longevity biotech and Retro’s progress in cellular reprogramming, autophagy and plasma programs. When longevity-focused decentralized science platform VitaDAO recently announced its latest funding round, one…
How Cyclarity is targeting atherosclerosis and giving the body the means to reverse disease from the inside out. Atherosclerosis is a killer, and while the risk factors can be lowered…
Mitrix Bio CEO and Founder on mitochondrial degradation – and how it drives aging and lifespan. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has been contracted by the company…
Amplifier Therapeutics is going after “one of the most sought-after drug targets in aging research”. Cambrian Bio, a clinical-stage biotech focused on treating and preventing chronic diseases of aging, has…
The latest longevity updates from our investment news desk. Remedium publishes gene therapy safety data Gene therapy company Remedium Bio announced the publication of pre-clinical data demonstrating the safety and…
New tricks: Loyal’s companion dog longevity study receives FDA protocol concurrence. Loyal, a clinical-stage veterinary medicine company developing drugs intended to extend the healthspan and lifespan of dogs, has announced…
The latest longevity updates from our investment news desk. ChromaDex reports ‘best quarter ever’ Healthy aging supplements company ChromaDex (NASDAQ: CDXC) announced its fourth quarter and fiscal year 2022…
